欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/0157/003
药品名称Cefotaxim Sandoz 2 g
活性成分
    • cefotaxime sodium salt 2.0 g
剂型Powder for solution for injection
上市许可持有人Sandoz GmbH Biochemiestrasse 10 A- 6250 KUNDL AUSTRIA
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Austria (AT)
      Cefotaxim Sandoz 2 g - Pulver zur Herstellung einer Injektions-/Infusionslösung
    • Sweden (SE)
许可日期2002/06/14
最近更新日期2012/08/16
药物ATC编码
    • J ANTIINFECTIVES FOR SYSTEMIC USE
    • J01 ANTIBACTERIALS FOR SYSTEMIC USE
    • J01D OTHER BETA-LACTAM ANTIBACTERIALS
    • J01DA Cephalosporins and related substances
    • J01DA10 Cefotaxime
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Article 4.8(a)(iii), first paragraph
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase